Ann: Appendix 4C - quarterly, page-7

Certainly disappointing to see the drop in advertising as this was being flagged as a major growth contributor. On the flip side, nice to see a decrease in expenses even with the New Zealand Launch and other operations.

That said, going to need to see a more significant moving of the dial on the revenue side before the broader market gets too excited I suspect. The drawdown on the loan certainly a positive that it avoids dilution, but new holders will likely see the debt as a further negative and now cash flow positive + repayment of debt will be what people are watching out for.

Looking forward to seeing some of the PetYeti and non optical results come through, most of the recent news has been health related so hopefully some latent subscriptions, usage and revenue to follow on and hit the books. Hopefully these arrive in conjunction with a resumption of advertising receipts and shareholders can see a patch to cash flow positivity, even if just on a quarterly basis to start with .